Fundraising Fox
/Companies
Sign in

20n

DefunctYC W15

San Francisco, US · 2 employees · 9 known investors

Find your way into 20n

Sign up to see every warm intro you have to 20n

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the 20n team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

20n uses machine learning and computational biology to predict DNA sequences for industrial biotech and pharmaceutical applications. The company serves manufacturing firms developing biologically-based alternatives to traditional chemical production of fuels, materials, therapeutics, and specialty chemicals.

Also known as 20n Labs, Inc.

AI & Machine LearningBiotechHealthtechArtificial IntelligenceUnited States of AmericaAmerica / Canada

Founders & leadership· Y Combinator alumni (W15)

SSSaurabh Srivastava
Saurabh SrivastavaCEO2014–2017Saurabh Srivastava completed a PhD and postdoctoral research in code synthesis using theorem provers. He served as Head of Code Research at Essential AI, and previously founded two YC-backed companies focused on code synthesis for biological and automation applications. He currently works on code model development at NVIDIA.
CAChris Anderson
Chris AndersonCSO2015–2017

Investors · 9

Blumberg CapitalreportedMiami · $500K – $5M

How we know: Y Combinator's founder network · Not right? Tell us

Great Oaks Venture CapitalreportedNew York · $50K – $500K

How we know: Y Combinator's founder network · Not right? Tell us

Khosla VenturesreportedMenlo Park · $100K – $20M

How we know: Y Combinator's founder network · Not right? Tell us

Lin, Bill | A10 Venturesreported

How we know: Y Combinator's founder network · Not right? Tell us

Point Reyes Managementreported

How we know: Y Combinator's founder network · Not right? Tell us

Prospect Venture PartnersreportedMenlo Park · $3M – $5M

How we know: Y Combinator's founder network · Not right? Tell us

SP Investment Fundreported

How we know: Y Combinator's founder network · Not right? Tell us

Venture Investment AssociatesreportedPeapack

How we know: Y Combinator's founder network · Not right? Tell us

Related companies · 5

RaycasterRaycaster is an AI workspace that reviews and revises regulatory and clinical documents (protocols, reports, modules, quality documentation) for biopharma companies to keep submissions aligned with scientific changes. It works on native document formats and traces impacts across interconnected dossiers for IND through lifecycle management.
RasynRasyn.ai offers Marigold, an AI research assistant that lets scientists ask research questions, run tools, or delegate entire tasks, returning results such as structures, charts, code, and papers in panels. It provides 54 runnable tools, 40 executing on connected hardware and 14 on hosted endpoints.
Evolvere BioSciencesEvolvere BioSciences develops antibiotics using computational models and evolutionary data to target pathogenic bacteria while preserving beneficial microbes, designed to resist the development of bacterial resistance.
Ångström AIÅngström AI develops AI-powered physics simulations for pharmaceutical drug discovery, computing molecular properties like solubility, lipophilicity, and crystal structure stability to replace traditional lab experiments. The platform uses machine learning interatomic potentials and free energy calculations to accelerate and derisk solid form development for pharma companies.
TwentyTwoTwenty Two develops AI-powered biosecurity infrastructure for screening and monitoring biological threats across the emerging bioeconomy. The platform provides automated customer screening, functional sequence prediction, and model safeguards to help organizations comply with dual-use research regulations.

Companies working in the same space as 20n.

Legal entities · 1

corporate structure
20n Labs, Inc.

Frequently asked questions

What does 20n do?
20n uses machine learning and computational biology to predict DNA sequences for industrial biotech and pharmaceutical applications. The company serves manufacturing firms developing biologically-based alternatives to traditional chemical production of fuels, materials, therapeutics, and specialty chemicals.
Who founded 20n?
20n was founded by Saurabh Srivastava, Chris Anderson.
Who are 20n's investors?
20n's investors include Y Combinator, Blumberg Capital, Great Oaks Venture Capital, Khosla Ventures, Lin, Bill | A10 Ventures, Point Reyes Management, Prospect Venture Partners, SP Investment Fund and 1 more.
Where is 20n headquartered?
20n is headquartered in San Francisco, US.